Cue Biopharma (CUE) Debt Ratio (2022 - 2025)

Cue Biopharma has disclosed Debt Ratio across 4 years of filings, most recently posting 0.05 for Q3 2025.

• Debt Ratio for Q3 2025 came in at 0.05, down 55.89% year-over-year; the trailing twelve-month figure through Sep 2025 was 0.05 (down 55.89% YoY), and the FY2024 annual result was 0.13, up 1.43% from the prior year.
• Debt Ratio came in at 0.05 for Q3 2025 at Cue Biopharma, down from 0.06 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.15 in Q1 2025 to a low of 0.05 in Q3 2025.
• The 4-year median for Debt Ratio is 0.13 (2022), against an average of 0.12.
• Across the five-year window, Debt Ratio increased 21.16% in 2023 and tumbled 56.89% in 2025, its largest moves.
• Cue Biopharma's Debt Ratio stood at 0.11 in 2022, then increased by 21.16% to 0.13 in 2023, then grew by 1.43% to 0.13 in 2024, then sank by 61.31% to 0.05 in 2025.
• The last three Debt Ratio figures came in at 0.05 (Q3 2025), 0.06 (Q2 2025), and 0.15 (Q1 2025), per Business Quant data.